Dual-label studies with [125I]-3(R)/[131I]-3(S)-BMIPP show similar metabolism in rat tissues

Florian T. Mokler, Qun Lin, Huimin Luo, Daniel W. McPherson, Arnold L. Beets, Andreas Bockisch, Joachim Kropp, F. F. Knapp

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Biodistribution studies with the radioiodinated 3(R)- and 3(S)isomers of 15-(p-iodophenyl)-3-methylpentadecanoic acid (BMIPP) in rats have shown that 3(R)-BMIPP has 20%-25% higher heart uptake than 3(S)-BMIPP (15-180 min). In contrast, the 3(S)-isomer has slightly higher liver uptake, and uptake in other tissues examined is similar. Methods: To evaluate the possible differences in metabolic fate of the two isomers, a mixture of [125I]- 3(R)/[131I]-3(S)-BMIPP was administered to fasted female Fisher rats. Groups of rats (3 per group) were killed 15, 60 and 180 min after administration. Urine and feces were collected from a fourth group (n = 3) over 7 d. Samples of blood, heart, liver, lungs, kidney and urine were Folch extracted. The distributions of 125I and 131I in the organic (lipid), aqueous and pellet samples were determined. The lipid samples as well as the organic fractions from base-hydrolyzed triglyceride (TG) fractions and acid- hydrolyzed urine samples were then analyzed by thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC). Results: The relative distributions of 125I and 131I in the lipid, aqueous and pellet samples were similar for both isomers. Distribution of 125I and 131I in the various components of the lipid extracts observed by TLC (hexane:ether:HOAc, 70:30:1) was also similar, with principal incorporation into the free fatty acid (FFA) and TG pools. HPLC analyses (C18) of the FFA fraction showed similar 125I and 131I profiles, corresponding to BMIPP, and the α-methyl-C14 (14-(p-iodophenyl)-3-(R,S)-methyltetradecanoic acid) and C12, C10 and C6 carbon chain-length catabolites. By TLC, radioactive components of 125I and 131I in the urine had the same TLC mobility as hippuric acid. HPLC analyses (C18) of acid-hydrolyzed urine gave a single 125I/131I component with the same relative retention time as 2-(p- iodophenyl)acetic acid, which is the final α/β-oxidative BMIPP catabolite. Unexpectedly, HPLC of lipids from base-hydrolyzed TG from the heart tissue showed 125I/131I components with the same retention times as shorter- chain fatty acids, similar to the FFA fraction, with only low levels of activity detected in BMIPP. Conclusion: These results show that 3(R)-BMIPP and 3(S)-BMIPP are metabolized similarly in rat tissues and that higher myocardial extraction observed for 3(R)-BMIPP may reflect differences in the relative membrane transport of the two isomers.

Original languageEnglish
Pages (from-to)1918-1927
Number of pages10
JournalJournal of Nuclear Medicine
Volume40
Issue number11
StatePublished - Nov 1999

Keywords

  • 3(R)/3(S)-15-(p-iodophenyl)-3- methylpentadecanoic acid
  • Cardiac imaging agents
  • Radioiodinated fatty acids

Fingerprint

Dive into the research topics of 'Dual-label studies with [125I]-3(R)/[131I]-3(S)-BMIPP show similar metabolism in rat tissues'. Together they form a unique fingerprint.

Cite this